I’d like to know your point of view about why this biotech closed end fund, in existence for more than 20 years, has reached a record of average discount of more than 15-20% for the last 10 years.

Any idea why?

Hera are some data.

- Inception date: Nov 1993

- Price and discount, 20 years:

- Portfolio:

- Total Expense Ratio

- Number of shares outstanding:

- Lat 3 weeks of Nav and Price

- Lat 3 weeks of volumes: